References
[1] Nicchi, S. et al. Decorating the surface of Escherichia coli with bacterial lipoproteins: a comparative analysis of different display systems. Microb Cell Fact 20, 33 (2021).
[2] Otto, C. et al. Antidiabetic Effects of a Tripeptide That Decreases Abundance of Na+-d-glucose Cotransporter SGLT1 in the Brush-Border Membrane of the Small Intestine. ACS Omega 5, 29127-29139 (2020).
[3] Zhu, J. et al. Metabolic engineering of Escherichia coli for efficient production of L-alanyl-L-glutamine. Microb Cell Fact 19, 129 (2020).
[4] Balagaddé, F. K. et al. A synthetic Escherichia coli predator-prey ecosystem. Mol Syst Biol 4, 187 (2008).
[5] Qiu, J., Zhai, Y., Wei, M., Zheng, C. & Jiao, X. Toxin-antitoxin systems: Classification, biological roles, and applications. Microbiological Research 264, 127159 (2022).
[6] Glass, D. S., & Riedel-Kruse, I. H. (2018). A Synthetic Bacterial Cell-Cell Adhesion Toolbox for Programming Multicellular Morphologies and Patterns. Cell, 174(3), 649-658.e616. doi:https://doi.org/10.1016/j.cell.2018.06.041
[7]Drolia,R.,Amalaradjou,M.A.R.,Ryan,V.,Tenguria,S.,Liu,D.,Bai,X.,Bhunia,A.K.(2020).Receptor-targeted engineered probiotics mitigate lethal Listeria infection. Nature Communications, 11(1), 6344. doi:10.1038/s41467-020-20200-5
[8] Planesse C, Nativel B, Iwema T, Gasque P, Robert-Da Silva C, Viranaïcken W. Recombinant human HSP60 produced in ClearColi™ BL21(DE3) does not activate the NFκB pathway. Cytokine. 2015 May;73(1):190-5. doi: 10.1016/j.cyto.2015.01.028.